A/Prof Villemagne graduated Cum Laude from the National University of Buenos Aires in 1983. He was awarded a Post-Doctoral Fellowship in Nuclear Medicine by the National Atomic Energy Commission in 1984, and continued his post-graduate studies at the Division of Nuclear Medicine at The Johns Hopkins Medical Institutions. He subsequently furthered his molecular neuroimaging training at the National Institute on Drug Abuse, NIH, and at the University of Pittsburgh. He now holds the appointment of Senior Research Fellow in Neuroscience at the Dept of Molecular Imaging & Therapy, Austin Health. Since 2003, he has performed several studies of new tracers for Aβ and tau with in vitro techniques and animal models and human PET and SPECT studies – including blood metabolite analysis and kinetic modeling for quantification of binding parameters-. A/Prof Villemagne have been principal or co-investigator in several national and international grants.
A/Prof Villemagne has authored or co-authored several book chapters and requested reviews on dementia imaging, and more than 260 original publications on PET research in leading international peer-reviewed journals, particularly in the field of neuroreceptor and amyloid and tau imaging studies. He has been invited to chair and present at national and international meetings in the area of biomarkers for Alzheimer’s disease and neurodegeneration. Among other honours, he has received the Foerderer Fund for Excellence Award from The Children’s Hospital of Philadelphia in 2002, the JAAME Fellowship from Japan in 2007 and the ANSTO Nuclear Medicine Award in 2010. More recently, he received the de Leon Prize in Neuroimaging – Senior Scientist by The Alzheimer’s Association of America (Boston, USA, 7/2013), and the Christopher Clark Award for the Continuing Advancement in the Field of Human Amyloid Imaging, Miami (USA, 17/01/2014). Since 2016, he was recognized as one of The World’s Most Influential Scientific Minds by Thomson Reuters (based on his citations being in the top 1% in the world in the field of Neuroscience).